ZA964261B - Prodrugs of paclitaxel derivatives. - Google Patents

Prodrugs of paclitaxel derivatives.

Info

Publication number
ZA964261B
ZA964261B ZA9604261A ZA964261A ZA964261B ZA 964261 B ZA964261 B ZA 964261B ZA 9604261 A ZA9604261 A ZA 9604261A ZA 964261 A ZA964261 A ZA 964261A ZA 964261 B ZA964261 B ZA 964261B
Authority
ZA
South Africa
Prior art keywords
prodrugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
ZA9604261A
Other languages
English (en)
Inventor
Paul M Scola
John F Kadow
Dolatrai M Vyas
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA964261B publication Critical patent/ZA964261B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9604261A 1995-06-06 1996-05-27 Prodrugs of paclitaxel derivatives. ZA964261B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ZA964261B true ZA964261B (en) 1997-11-27

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604261A ZA964261B (en) 1995-06-06 1996-05-27 Prodrugs of paclitaxel derivatives.

Country Status (23)

Country Link
EP (1) EP0747385B1 (fr)
JP (1) JPH08337589A (fr)
KR (1) KR100375956B1 (fr)
CN (1) CN1066151C (fr)
AR (1) AR002756A1 (fr)
AT (1) ATE222259T1 (fr)
AU (1) AU695959B2 (fr)
CA (1) CA2176191A1 (fr)
CZ (1) CZ291516B6 (fr)
DE (1) DE69622933T2 (fr)
DK (1) DK0747385T3 (fr)
ES (1) ES2181824T3 (fr)
HU (1) HUP9601524A3 (fr)
IL (1) IL118526A (fr)
MX (1) MX9601994A (fr)
NO (1) NO315233B1 (fr)
NZ (1) NZ286723A (fr)
PL (1) PL187883B1 (fr)
PT (1) PT747385E (fr)
RU (1) RU2162082C2 (fr)
SG (1) SG72692A1 (fr)
TW (1) TW354293B (fr)
ZA (1) ZA964261B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
HUP0003546A3 (en) * 1997-05-27 2002-12-28 Baker Norton Pharma Compositions for administering taxanes orally to human patients
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP2002537262A (ja) * 1999-02-18 2002-11-05 オキシジェン，インコーポレイティド 血管破壊のターゲッティングに使用するための組成物および方法
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
JP2003522170A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ７カーボネート置換タキサン
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
WO2005087222A1 (fr) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. Taxanes a substitution de c7 lactyloxy-
CN101146514B (zh) * 2005-02-18 2013-03-27 阿布拉西斯生物科学公司 用于整合入医疗装置的疏水性改善的药物
US20160024084A1 (en) 2013-03-15 2016-01-28 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (fr) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Dérivés deutériés d'intédanib et leur utilisation pour le traitement de troubles prolifératifs
US20180318268A1 (en) * 2015-11-19 2018-11-08 Biohaven Pharmaceutical Holding Company Ltd. Amine prodrugs of pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111527C (fr) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethylethers de derives du taxane
CA2129288C (fr) * 1993-08-17 2000-05-16 Jerzy Golik Esters phosphonooxymethyliques de derives de taxane

Also Published As

Publication number Publication date
ES2181824T3 (es) 2003-03-01
CA2176191A1 (fr) 1996-12-07
KR100375956B1 (ko) 2003-04-21
CN1066151C (zh) 2001-05-23
IL118526A (en) 2001-05-20
ATE222259T1 (de) 2002-08-15
AU5471896A (en) 1996-12-19
MX9601994A (es) 1997-08-30
HUP9601524A2 (en) 1997-05-28
CZ291516B6 (cs) 2003-03-12
PL314637A1 (en) 1996-12-09
JPH08337589A (ja) 1996-12-24
NO962231D0 (no) 1996-05-31
EP0747385B1 (fr) 2002-08-14
TW354293B (en) 1999-03-11
HUP9601524A3 (en) 2000-03-28
NO315233B1 (no) 2003-08-04
AU695959B2 (en) 1998-08-27
HU9601524D0 (en) 1996-07-29
DE69622933D1 (de) 2002-09-19
RU2162082C2 (ru) 2001-01-20
NZ286723A (en) 1998-03-25
CN1144805A (zh) 1997-03-12
SG72692A1 (en) 2000-05-23
DK0747385T3 (da) 2002-12-16
AR002756A1 (es) 1998-04-29
IL118526A0 (en) 1996-10-16
PL187883B1 (pl) 2004-10-29
DE69622933T2 (de) 2003-04-24
CZ156396A3 (en) 1996-12-11
KR970000222A (ko) 1997-01-21
NO962231L (no) 1996-12-09
PT747385E (pt) 2002-11-29
EP0747385A1 (fr) 1996-12-11

Similar Documents

Publication Publication Date Title
ZA961444B (en) Pyrazolylbenzoyl derivatives.
GB2306473A8 (en) Glucoxide derivatives
ZA964261B (en) Prodrugs of paclitaxel derivatives.
HU9603071D0 (en) Purin-6-one derivatives
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
HUP9600107A2 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
SG48455A1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CY2221B1 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
IL117989A0 (en) Chromone derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
ZA967741B (en) Diarylalkenylamine derivatives.
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
GB9516349D0 (en) Aza-anthracyclinone derivatives
HU9600213D0 (en) 4-mercapto-benzoyl-guanidine derivatives
ZA964034B (en) N-aminopyridone derivatives.
EP0804205A4 (fr) Derives de 4-aza-19-norandrostane
GB2308593A (en) Imidazopyridedine derivatives